Primary completion date changed
Before: 31 Dec 2026. After: 31 Oct 2026.
Recruitment status changed
Before: Recruiting. After: Active not recruiting.
Study sponsor: TG Therapeutics, Inc. · TGTX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 31 Dec 2026. After: 31 Oct 2026.
Before: Recruiting. After: Active not recruiting.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Area under the curve (AUC) from 0 to Week 24 of Ublituximab. After: Measure: Area Under the Curve From Week 0 to Week 24 (AUC0-W24) of Ublituximab.